Drug Shortage Report for SANDOZ CIPROFLOXACIN / DEXAMETHASONE

Last updated on 2024-01-31 History
Report ID 216164
Drug Identification Number 02506882
Brand name SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Common or Proper name CIPROFLOXACIN / DEXAMETHASONE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE CIPROFLOXACIN
Strength(s) 0.1% 0.3%
Dosage form(s) SUSPENSION
Route of administration OTIC
Packaging size 7.5ML
ATC code S02CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-16
Estimated end date 2024-02-02
Actual end date 2024-01-30
Shortage status Resolved
Updated date 2024-01-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-01-31 English Compare
v8 2024-01-30 French Compare
v7 2024-01-30 English Compare
v6 2024-01-23 French Compare
v5 2024-01-23 English Compare
v4 2024-01-17 English Compare
v3 2024-01-16 French Compare
v2 2024-01-16 English Compare
v1 2024-01-16 English Compare

Showing 1 to 9 of 9